MARKET OVERVIEW
Live cell imaging is the technique to study live cells with the help of images obtained from imaging systems such as high content screening systems and microscopes. This method is used by the scientists to obtain a better view of the cell's biological function by studying the cellular dynamics. In recent years, live cell imaging technology has been widely accepted by various researchers to obtain a better knowledge regarding cell biology. Live cell imaging plays a crucial role in research fields such as neurology, immunology, microbiology and, genetics among others.
MARKET SCOPE
The "Global Live Cell Imaging Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the live cell imaging market with detailed market segmentation by product, technology, application, end user, and geography. The report provides key statistics on the market status of the leading live cell imaging market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product, the global live cell imaging market is segmented into equipment, kits and reagents, software, consumables.
- On the basis of technology, the market is segmented into fluorescence recovery after photobleaching, fluorescence resonance energy transfer, high-content analysis, fluorescence in situ hybridization, and others.
- Based on application, the market is bifurcated into Drug Discovery, Cell Biology, Developmental Biology,, Stem Cells, Others.
- Based on end user, the market is segmented into pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, and others.
MARKET DYNAMICS
Drivers
- Rising number of government funds for research and development activities.
- Increasing number of cancer cases worldwide
- Increasing adoption of biotechnology-based personalized medicine.
Restraints-
- Under-developed research sector in a few developing countries
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The live cell imaging market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the live cell imaging market in these regions.
IMPACT OF COVID-19 ON LIVE CELL IMAGING MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Akshay Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any. 
Have a question?
Speak to Analyst
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The live cell imaging market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the live cell imaging market in these regions.
IMPACT OF COVID-19 ON LIVE CELL IMAGING MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the live cell imaging market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from live cell imaging market are anticipated to lucrative growth opportunities in the future with the rising demand for live cell imaging in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the live cell imaging market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- General Electric
- Olympus Corporation
- BioTek Instruments, Inc.
- Molecular Devices, LLC.
- CYTOSKELETON, INC.
- Bruker
- Nikon Instruments Inc.
- Merck KGaA
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Live Cell Imaging Market - By Product
1.3.2 Live Cell Imaging Market - By Technology
1.3.3 Live Cell Imaging Market - By Application
1.3.4 Live Cell Imaging Market - By End User
1.3.5 Live Cell Imaging Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LIVE CELL IMAGING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LIVE CELL IMAGING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LIVE CELL IMAGING MARKET - GLOBAL MARKET ANALYSIS
6.1. LIVE CELL IMAGING - GLOBAL MARKET OVERVIEW
6.2. LIVE CELL IMAGING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. LIVE CELL IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. EQUIPMENT
7.3.1. Overview
7.3.2. Equipment Market Forecast and Analysis
7.4. KITS AND REAGENTS
7.4.1. Overview
7.4.2. Kits and Reagents Market Forecast and Analysis
7.5. SOFTWARE
7.5.1. Overview
7.5.2. Software Market Forecast and Analysis
7.6. CONSUMABLES
7.6.1. Overview
7.6.2. Consumables Market Forecast and Analysis
8. LIVE CELL IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING
8.3.1. Overview
8.3.2. Fluorescence Recovery After Photobleaching Market Forecast and Analysis
8.4. FLUORESCENCE RESONANCE ENERGY TRANSFER
8.4.1. Overview
8.4.2. Fluorescence Resonance Energy Transfer Market Forecast and Analysis
8.5. HIGH-CONTENT ANALYSIS
8.5.1. Overview
8.5.2. High-content Analysis Market Forecast and Analysis
8.6. FLUORESCENCE IN SITU HYBRIDIZATION
8.6.1. Overview
8.6.2. Fluorescence In Situ Hybridization Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. LIVE CELL IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DRUG DISCOVERY
9.3.1. Overview
9.3.2. Drug Discovery Market Forecast and Analysis
9.4. CELL BIOLOGY
9.4.1. Overview
9.4.2. Cell Biology Market Forecast and Analysis
9.5. DEVELOPMENTAL BIOLOGY
9.5.1. Overview
9.5.2. Developmental Biology Market Forecast and Analysis
9.6. STEM CELLS
9.6.1. Overview
9.6.2. Stem Cells Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. LIVE CELL IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
10.4. HOSPITALS
10.4.1. Overview
10.4.2. Hospitals Market Forecast and Analysis
10.5. DIAGNOSTIC LABORATORIES
10.5.1. Overview
10.5.2. Diagnostic Laboratories Market Forecast and Analysis
10.6. OTHERS
10.6.1. Overview
10.6.2. Others Market Forecast and Analysis
11. LIVE CELL IMAGING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Live Cell Imaging Market Overview
11.1.2 North America Live Cell Imaging Market Forecasts and Analysis
11.1.3 North America Live Cell Imaging Market Forecasts and Analysis - By Product
11.1.4 North America Live Cell Imaging Market Forecasts and Analysis - By Technology
11.1.5 North America Live Cell Imaging Market Forecasts and Analysis - By Application
11.1.6 North America Live Cell Imaging Market Forecasts and Analysis - By End User
11.1.7 North America Live Cell Imaging Market Forecasts and Analysis - By Countries
11.1.7.1 United States Live Cell Imaging Market
11.1.7.1.1 United States Live Cell Imaging Market by Product
11.1.7.1.2 United States Live Cell Imaging Market by Technology
11.1.7.1.3 United States Live Cell Imaging Market by Application
11.1.7.1.4 United States Live Cell Imaging Market by End User
11.1.7.2 Canada Live Cell Imaging Market
11.1.7.2.1 Canada Live Cell Imaging Market by Product
11.1.7.2.2 Canada Live Cell Imaging Market by Technology
11.1.7.2.3 Canada Live Cell Imaging Market by Application
11.1.7.2.4 Canada Live Cell Imaging Market by End User
11.1.7.3 Mexico Live Cell Imaging Market
11.1.7.3.1 Mexico Live Cell Imaging Market by Product
11.1.7.3.2 Mexico Live Cell Imaging Market by Technology
11.1.7.3.3 Mexico Live Cell Imaging Market by Application
11.1.7.3.4 Mexico Live Cell Imaging Market by End User
11.2. EUROPE
11.2.1 Europe Live Cell Imaging Market Overview
11.2.2 Europe Live Cell Imaging Market Forecasts and Analysis
11.2.3 Europe Live Cell Imaging Market Forecasts and Analysis - By Product
11.2.4 Europe Live Cell Imaging Market Forecasts and Analysis - By Technology
11.2.5 Europe Live Cell Imaging Market Forecasts and Analysis - By Application
11.2.6 Europe Live Cell Imaging Market Forecasts and Analysis - By End User
11.2.7 Europe Live Cell Imaging Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Live Cell Imaging Market
11.2.7.1.1 Germany Live Cell Imaging Market by Product
11.2.7.1.2 Germany Live Cell Imaging Market by Technology
11.2.7.1.3 Germany Live Cell Imaging Market by Application
11.2.7.1.4 Germany Live Cell Imaging Market by End User
11.2.7.2 France Live Cell Imaging Market
11.2.7.2.1 France Live Cell Imaging Market by Product
11.2.7.2.2 France Live Cell Imaging Market by Technology
11.2.7.2.3 France Live Cell Imaging Market by Application
11.2.7.2.4 France Live Cell Imaging Market by End User
11.2.7.3 Italy Live Cell Imaging Market
11.2.7.3.1 Italy Live Cell Imaging Market by Product
11.2.7.3.2 Italy Live Cell Imaging Market by Technology
11.2.7.3.3 Italy Live Cell Imaging Market by Application
11.2.7.3.4 Italy Live Cell Imaging Market by End User
11.2.7.4 Spain Live Cell Imaging Market
11.2.7.4.1 Spain Live Cell Imaging Market by Product
11.2.7.4.2 Spain Live Cell Imaging Market by Technology
11.2.7.4.3 Spain Live Cell Imaging Market by Application
11.2.7.4.4 Spain Live Cell Imaging Market by End User
11.2.7.5 United Kingdom Live Cell Imaging Market
11.2.7.5.1 United Kingdom Live Cell Imaging Market by Product
11.2.7.5.2 United Kingdom Live Cell Imaging Market by Technology
11.2.7.5.3 United Kingdom Live Cell Imaging Market by Application
11.2.7.5.4 United Kingdom Live Cell Imaging Market by End User
11.2.7.6 Rest of Europe Live Cell Imaging Market
11.2.7.6.1 Rest of Europe Live Cell Imaging Market by Product
11.2.7.6.2 Rest of Europe Live Cell Imaging Market by Technology
11.2.7.6.3 Rest of Europe Live Cell Imaging Market by Application
11.2.7.6.4 Rest of Europe Live Cell Imaging Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Live Cell Imaging Market Overview
11.3.2 Asia-Pacific Live Cell Imaging Market Forecasts and Analysis
11.3.3 Asia-Pacific Live Cell Imaging Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Live Cell Imaging Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Live Cell Imaging Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Live Cell Imaging Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Live Cell Imaging Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Live Cell Imaging Market
11.3.7.1.1 Australia Live Cell Imaging Market by Product
11.3.7.1.2 Australia Live Cell Imaging Market by Technology
11.3.7.1.3 Australia Live Cell Imaging Market by Application
11.3.7.1.4 Australia Live Cell Imaging Market by End User
11.3.7.2 China Live Cell Imaging Market
11.3.7.2.1 China Live Cell Imaging Market by Product
11.3.7.2.2 China Live Cell Imaging Market by Technology
11.3.7.2.3 China Live Cell Imaging Market by Application
11.3.7.2.4 China Live Cell Imaging Market by End User
11.3.7.3 India Live Cell Imaging Market
11.3.7.3.1 India Live Cell Imaging Market by Product
11.3.7.3.2 India Live Cell Imaging Market by Technology
11.3.7.3.3 India Live Cell Imaging Market by Application
11.3.7.3.4 India Live Cell Imaging Market by End User
11.3.7.4 Japan Live Cell Imaging Market
11.3.7.4.1 Japan Live Cell Imaging Market by Product
11.3.7.4.2 Japan Live Cell Imaging Market by Technology
11.3.7.4.3 Japan Live Cell Imaging Market by Application
11.3.7.4.4 Japan Live Cell Imaging Market by End User
11.3.7.5 South Korea Live Cell Imaging Market
11.3.7.5.1 South Korea Live Cell Imaging Market by Product
11.3.7.5.2 South Korea Live Cell Imaging Market by Technology
11.3.7.5.3 South Korea Live Cell Imaging Market by Application
11.3.7.5.4 South Korea Live Cell Imaging Market by End User
11.3.7.6 Rest of Asia-Pacific Live Cell Imaging Market
11.3.7.6.1 Rest of Asia-Pacific Live Cell Imaging Market by Product
11.3.7.6.2 Rest of Asia-Pacific Live Cell Imaging Market by Technology
11.3.7.6.3 Rest of Asia-Pacific Live Cell Imaging Market by Application
11.3.7.6.4 Rest of Asia-Pacific Live Cell Imaging Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Live Cell Imaging Market Overview
11.4.2 Middle East and Africa Live Cell Imaging Market Forecasts and Analysis
11.4.3 Middle East and Africa Live Cell Imaging Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Live Cell Imaging Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Live Cell Imaging Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Live Cell Imaging Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Live Cell Imaging Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Live Cell Imaging Market
11.4.7.1.1 South Africa Live Cell Imaging Market by Product
11.4.7.1.2 South Africa Live Cell Imaging Market by Technology
11.4.7.1.3 South Africa Live Cell Imaging Market by Application
11.4.7.1.4 South Africa Live Cell Imaging Market by End User
11.4.7.2 Saudi Arabia Live Cell Imaging Market
11.4.7.2.1 Saudi Arabia Live Cell Imaging Market by Product
11.4.7.2.2 Saudi Arabia Live Cell Imaging Market by Technology
11.4.7.2.3 Saudi Arabia Live Cell Imaging Market by Application
11.4.7.2.4 Saudi Arabia Live Cell Imaging Market by End User
11.4.7.3 U.A.E Live Cell Imaging Market
11.4.7.3.1 U.A.E Live Cell Imaging Market by Product
11.4.7.3.2 U.A.E Live Cell Imaging Market by Technology
11.4.7.3.3 U.A.E Live Cell Imaging Market by Application
11.4.7.3.4 U.A.E Live Cell Imaging Market by End User
11.4.7.4 Rest of Middle East and Africa Live Cell Imaging Market
11.4.7.4.1 Rest of Middle East and Africa Live Cell Imaging Market by Product
11.4.7.4.2 Rest of Middle East and Africa Live Cell Imaging Market by Technology
11.4.7.4.3 Rest of Middle East and Africa Live Cell Imaging Market by Application
11.4.7.4.4 Rest of Middle East and Africa Live Cell Imaging Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Live Cell Imaging Market Overview
11.5.2 South and Central America Live Cell Imaging Market Forecasts and Analysis
11.5.3 South and Central America Live Cell Imaging Market Forecasts and Analysis - By Product
11.5.4 South and Central America Live Cell Imaging Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Live Cell Imaging Market Forecasts and Analysis - By Application
11.5.6 South and Central America Live Cell Imaging Market Forecasts and Analysis - By End User
11.5.7 South and Central America Live Cell Imaging Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Live Cell Imaging Market
11.5.7.1.1 Brazil Live Cell Imaging Market by Product
11.5.7.1.2 Brazil Live Cell Imaging Market by Technology
11.5.7.1.3 Brazil Live Cell Imaging Market by Application
11.5.7.1.4 Brazil Live Cell Imaging Market by End User
11.5.7.2 Argentina Live Cell Imaging Market
11.5.7.2.1 Argentina Live Cell Imaging Market by Product
11.5.7.2.2 Argentina Live Cell Imaging Market by Technology
11.5.7.2.3 Argentina Live Cell Imaging Market by Application
11.5.7.2.4 Argentina Live Cell Imaging Market by End User
11.5.7.3 Rest of South and Central America Live Cell Imaging Market
11.5.7.3.1 Rest of South and Central America Live Cell Imaging Market by Product
11.5.7.3.2 Rest of South and Central America Live Cell Imaging Market by Technology
11.5.7.3.3 Rest of South and Central America Live Cell Imaging Market by Application
11.5.7.3.4 Rest of South and Central America Live Cell Imaging Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL LIVE CELL IMAGING MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. LIVE CELL IMAGING MARKET, KEY COMPANY PROFILES
14.1. THERMO FISHER SCIENTIFIC INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. PERKINELMER INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. GE HEALTHCARE
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. OLYMPUS CORPORATION
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. BIOTEK INSTRUMENTS, INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. MOLECULAR DEVICES, LLC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. CYTOSKELETON, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. BRUKER CORPORATION
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. NIKON CORPORATION
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. MERCK KGAA
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
1. Thermo Fisher Scientific Inc.
2. PerkinElmer Inc.
3. General Electric
4. Olympus Corporation
5. BioTek Instruments, Inc.
6. Molecular Devices, LLC.
7. CYTOSKELETON, INC.
8. Bruker
9. Nikon Instruments Inc.
10. Merck KGaA
11. Keyence Corporation
12. NanoLive SA
13. Sony Biotechnology Inc.
14. Phase Focus
15. Logos Biosystems (Aligned Genetics, Inc.)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Live Cell Imaging Market
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Apr 2024